SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 25, 2024 |
Oct. 31, 2024 |
Oct. 31, 2023 |
Oct. 31, 2024 |
Oct. 31, 2023 |
Nov. 27, 2024 |
Apr. 30, 2024 |
Apr. 30, 2023 |
Apr. 10, 2023 |
Mar. 31, 2022 |
Mar. 18, 2022 |
|
| Subsequent Event [Line Items] | |||||||||||
| Consulting fee | $ 661,954 | $ 695,216 | $ 1,314,443 | $ 2,041,178 | |||||||
| Aggregate shares | 870,000 | 870,000 | 625,000 | 625,000 | |||||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||
| November 2024 Agreement [Member] | Subsequent Event [Member] | |||||||||||
| Subsequent Event [Line Items] | |||||||||||
| Issuance of common stock for services, shares | 19,779 | ||||||||||
| Consulting fee | $ 65,000 | ||||||||||
| November 2024 Agreement [Member] | Director [Member] | Subsequent Event [Member] | |||||||||||
| Subsequent Event [Line Items] | |||||||||||
| Consulting fee | $ 250,000 | ||||||||||
| Securities Purchase Agreement [Member] | Subsequent Event [Member] | |||||||||||
| Subsequent Event [Line Items] | |||||||||||
| Aggregate shares | 1,457,700 | ||||||||||
| Common stock, par value | $ 0.001 | ||||||||||
| Purchase price | $ 7.00 | ||||||||||
| Warrants to purchase common stock | 728,850 | ||||||||||
| Warrants exercise price | $ 9.50 | ||||||||||
| X | ||||||||||
- Definition Payment of consulting services. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|